Vancouver, BC, April 01, 2019 (GLOBE NEWSWIRE) -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) is pleased to have made its inaugural shipment to the Ontario Cannabis Store, marking the Company’s entrance to Canada’s largest market. Adult recreational consumers in Ontario will soon have the opportunity to experience Invictus premium All Kush and Sensi Star cultivars, which will be available for purchase on www.ocs.ca.
“Our goal is to participate in all attractive markets through an innovative and differentiated product portfolio, with a vision to become a global player in both medical and adult-use recreational cannabis” said George E. Kveton, President and CEO of Invictus. “Today, we are proud to have achieved an important milestone on our growth path, one province at a time.”
Invictus products are available today under the Company’s wholly-owned subsidiary Acreage Pharms Ltd. To date, Invictus has secured provincial supply agreements for the adult recreational markets in British Columbia, Alberta, Saskatchewan and Ontario. Additionally, Invictus has signed a five-year supply and distribution agreement for medical cannabis with Deutsche Medizinalcannabis GmbH in Germany, with similar off-take opportunities available to Invictus commensurate with additional product supply coming online.
For more information, please visit the new website at www.invictus-md.com.
On Behalf of the Board,
George E. Kveton
Chief Executive Officer and Director
Vice President, Public Relations and Regulatory Affairs
Invictus is a global cannabis company offering a selection of products under a wide range of brands. Our integrated sales approach is defined by five pillars of distribution including medical, adult-use, international, Licensed Producer to Licensed Producer and retail stores.
Invictus has partnered with business leaders to convey our corporate vision, including KISS music legend and business mogul Gene Simmons as our Chief Evangelist Officer. To meet growing demand, Invictus is expanding its cultivation footprint, with three cannabis production facilities licensed under the Cannabis Act and Cannabis Regulations in Canada. To accommodate international sales, Invictus’ wholly-owned subsidiary, Acreage Pharms Ltd., has designed and is currently building its Phase 3 purpose-built cultivation facility to be European Union Good Manufacturing Practices (“EU-GMP”) compliant. The Company is targeting up to 50 percent of production to medical cannabis. To ensure consistency in quality and supply, Invictus maintains all aspects of the growing process through its subsidiary, Future Harvest Development Ltd. (“Future Harvest”), a high-quality fertilizer and nutrients manufacturer. Invictus drives sustainable long-term shareholder value through a diversified product portfolio with over 70 Health Canada approved strains and a multifaceted distribution strategy including medical, adult-use, international, Licensed Producer to Licensed Producer and retail stores. For more information visit www.invictus-md.com.
Neither the TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.